Verified employee & interview reviews

GE HealthCare Reviews

Chicago, Illinois

4.0/ 5

1 review

GE HealthCare Technologies Inc. is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator. Headquartered in Chicago, Illinois, the company operates as an independent public entity following its successful spin-off from the American conglomerate General Electric (GE) on January 3, 2023. Tracing its historical roots back to the Victor Electric Company founded in 1893, GE HealthCare boasts a rich legacy of over 130 years of medical innovation. Today, the company trades publicly on the Nasdaq exchange under the ticker symbol GEHC and is led by President and CEO Peter J. Arduini. The company operates a vast global footprint, serving more than one billion patients annually across over 160 countries. Its extensive infrastructure includes an installed base of over 5 million pieces of equipment worldwide. Strategically, GE HealthCare focuses on advancing "precision care"—an approach that integrates advanced medical hardware, sophisticated software, artificial intelligence, and pharmaceutical diagnostics to help clinicians diagnose diseases earlier, customize patient treatments, and maximize operational efficiency in resource-constrained health systems. GE HealthCare’s core business operations are structured into four primary segments: - Imaging: This division encompasses molecular imaging, computed tomography (CT) scanning, magnetic resonance imaging (MRI), X-ray systems, women's health screening (such as mammography), and interventional guidance systems. - Ultrasound: The company delivers specialized ultrasound systems tailored for general imaging, cardiovascular health, point-of-care, surgical guidance, handheld devices, and women's health. - Patient Care Solutions (PCS): This segment provides critical medical devices, consumables, digital solutions, and services used in acute and perioperative settings, including patient monitoring, diagnostic cardiology, anesthesia delivery, respiratory care, and maternal-infant care. - Pharmaceutical Diagnostics (PDx): As a world-leading supplier, this division develops and manufactures contrast media (such as Omnipaque and Visipaque) and molecular imaging radiopharmaceutical tracers required to enhance the clarity of diagnostic scans.Financially, GE HealthCare generates roughly $19 billion to $20 billion in annual revenue, drawing a significant portion from recurring service contracts, equipment upgrades, software licenses, and diagnostic consumables. The company heavily prioritizes research and development, investing billions into product pipelines. This focus has established GE HealthCare as an industry leader in digital health, frequently topping the FDA's list for the most AI-enabled medical device authorizations. Key proprietary brands under its umbrella include SIGNA (MRI), Revolution (CT), and CARESCAPE (patient monitoring). The company maintains major regional hubs worldwide, including its largest global R&D center in Bangalore, India, and critical manufacturing facilities in regions like Norway, France, and China.